1-3 of 3
Kate A Markey, MBBS, PhD
Close
Sort by
Journal Articles

TCR Repertoires in Graft-Versus-Host-Disease (GVHD)-Target Tissues Reveals Tissue Specificity of the Alloimmune Response

Susan DeWolf, MD, Katherine Nichols, Chi L. Nguyen, Paul A Giardina, John B. Slingerland, Harold Elias, MD, Rajya Kappangantula, Priscilla Baez, Rajmohan Murali, MD, Akimasa Hayashi, MD PhD, Anqi Dai, Heather J Landau, MD, Roni Tamari, MD, Alan M. Hanash, MD PhD, Robert Jenq, MD, Sergio Giralt, MD, Miguel-Angel Perales, MD, Kate A Markey, MBBS, PhD FRACP, Christine Iacobuzio-Donahue, MD PhD, Marcel van den Brink, MD PhD, Jonathan U Peled, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–23.
https://doi.org/10.1182/blood-2020-141018
Published: 2020
Journal Articles

In Vivo Expansion of Recipient DC Leads to Deletion of Donor Alloreactive CD8 + T Cells and Is an Alternative to Post-Transplant Cyclophosphamide for the Prevention of Graft-Versus-Host Disease after BMT

Kate A Markey, MBBS, PhD, Rachel D Kuns, BSc, Daniel J Browne, BSc, Kate H Gartlan, PhD, Renee J Robb, PhD, J Paulo Martins, BSc, Andrea S Henden, MBBS, Simone A Minnie, BSc, Melody Cheong, PhD, Motoko Koyama, MD PhD, Mark J Smyth, PhD, Gabrielle T Belz, PhD, Thomas Brocker, PhD, Mariapia Degli-Esposti, PhD, Steven W. Lane, MD PhD, Geoff R Hill, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4443.
https://doi.org/10.1182/blood.V130.Suppl_1.4443.4443
Published: 2017
Journal Articles

Recipient CD8 + DC Delete Alloreactive Donor CTL and Promote Leukemic Relapse after Allogeneic BMT

Kate A Markey, MBBS, PhD, Rachel D Kuns, BSc, Renee J Robb, PhD, Motoko Koyama, MDPhD, Kate Helen Gartlan, PhD, Andrea S Henden, MBBS, Simone A Minnie, B Sc, Kelli P A Macdonald, PhD, Thomas Brocker, PhD, Gabrielle T Belz, PhD, Steven W. Lane, MD, Geoff R Hill, MD
Journal: Blood
Blood (2015) 126 (23): 4279.
https://doi.org/10.1182/blood.V126.23.4279.4279
Published: 2015